Results 181 to 190 of about 17,710 (254)
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World Study. [PDF]
Carriera L +13 more
europepmc +1 more source
Dupilumab in Severe Asthma-COPD Overlap: Real-Life Experience on a Case Series. [PDF]
Sposato B +12 more
europepmc +1 more source
Efficacy of abrocitinib and dupilumab in itch‐dominant atopic dermatitis: An analysis of 2 trials
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Jonathan I. Silverberg +10 more
wiley +1 more source
ABSTRACT We present here a repository of key regulatory questions answered in centralized procedures and evaluate the place of modeling and simulation in marketing authorization process for biologics approved for the treatment of moderate‐to‐severe asthma from 2014 to 2024.
Hélène Haguet +2 more
wiley +1 more source
Risk assessment of asthma and allergic rhinitis in atopic dermatitis patients treated with biologics and JAK inhibitors: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Zeng L +8 more
europepmc +1 more source
Is allergic sensitization relevant in severe asthma? Which allergens may be culprits? [PDF]
core +1 more source
ABSTRACT Chronic rhinosinusitis (CRS) and asthma are prevalent conditions that often coexist. These diseases share common inflammatory mechanisms, such as T‐helper cell 2 (T2)‐high inflammation, driven by interleukin (IL)‐4, IL‐5, and IL‐13 cytokines.
Sanna Toppila‐Salmi +21 more
wiley +1 more source
Understanding Biologics in CRSwNP: Related Events and Insights. [PDF]
Izquierdo-Domínguez A +4 more
europepmc +1 more source

